GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA
Clinical trials for GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy cocktails show promise for Tough-to-Treat stomach and esophageal cancers
Disease control CompletedThis study tested several immunotherapy-based drug combinations in 214 people with advanced stomach, gastroesophageal junction, or esophageal cancer that could not be removed by surgery or had spread. Participants were grouped by prior treatment history and received either a comb…
Matched conditions: GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Plant extract shows promise for chemo-induced diarrhea in GI cancer patients
Symptom relief CompletedThis study tested a concentrated plant compound (CPC) as a nutritional supplement to standard diarrhea treatment in 30 people with stomach, esophageal, or colorectal cancer who had diarrhea from chemotherapy. The goal was to see if CPC could help stop the diarrhea faster. Results…
Matched conditions: GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC